Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The impact of pontine disease on lower urinary tract symptoms in patients with multiple sclerosis.
Evaluating risks, costs, and benefits of new and emerging therapies to optimize outcomes in multiple sclerosis.
Post subthalamic area deep brain stimulation for tremors: a mini-review.
Aquaporin water channels in the nervous system.
Subclinical Optic Neuritis in Neuromyelitis Optica.
[NMO Spectrum Disorders and Anti AQP4 Antibody].
Role of the Human Endogenous Retrovirus HERV-K18 in Autoimmune Disease Susceptibility: Study in the Spanish Population and Meta-Analysis.
Specific protein profile in cerebrospinal fluid from HIV-1-positive cART-treated patients affected by neurological disorders.
Quantitative metabolic profiling of lipid mediators.
A new model for primary-progressive multiple sclerosis?
Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study.
Comparative diagnostic accuracy of ganglion cell-inner plexiform and retinal nerve fiber layer thickness measures by cirrus and spectralis optical coherence tomography in relapsing-remitting multiple sclerosis.
Retinal Damage and Vision Loss in African-American Multiple Sclerosis Patients.
Cost-Effectiveness Analysis of OnabotulinumtoxinA (BOTOX(®)) for the Management of Urinary Incontinence in Adults with Neurogenic Detrusor Overactivity: A UK Perspective.
The best clinical paper on multiple sclerosis in 2014: Herodotus and Chataway - Commentary.
Utility of the rio score and modified rio score in korean patients with multiple sclerosis.
Comparison of antibodies hydrolyzing myelin basic protein from the cerebrospinal fluid and serum of patients with multiple sclerosis.
Relationship between Working Hours and Power of Attention, Memory, Fatigue, Depression and Self-Efficacy One Year after Diagnosis of Clinically Isolated Syndrome and Relapsing Remitting Multiple Sclerosis.
Study of curcumin immunomodulatory effects on reactive astrocyte cell function.
Polymorphisms in the genes coding for iron binding and transporting proteins are associated with disability, severity, and early progression in multiple sclerosis.
Specialized housing and transportation needs of adults with multiple sclerosis.
Induction and molecular signature of pathogenic T(H)17 cells.
Temperature dependence of water diffusion pools in brain white matter.
Hypogeusia as a symptom of neuromyelitis optica spectrum disorder.
The effectiveness of fingolimod in a Portuguese real-world population.
Pages
« first
‹ previous
…
370
371
372
373
374
375
376
377
378
…
next ›
last »